首页> 外国专利> IN VITRO USE OF POLYPEPTIDE FACTORS OR FRAGMENT THEREOF AS A DOWNSTREAM TARGET OF A DOWNSTREAM MARKER OF PI3K PATHWAY IN DRUG SCREEN, DESIGN AND DEVELOPMENT

IN VITRO USE OF POLYPEPTIDE FACTORS OR FRAGMENT THEREOF AS A DOWNSTREAM TARGET OF A DOWNSTREAM MARKER OF PI3K PATHWAY IN DRUG SCREEN, DESIGN AND DEVELOPMENT

机译:多肽因子或其片段的体外使用作为药物屏幕PI3K通路下游标记的下游目标,设计和开发

摘要

The present invention is related to a nucleic acid coding for a factor involved in a biological process, whereby the process is a PI 3-kinase pathway regulated process, preferably a process selected from the group comprising glucose metabolism, amino acid and glucose deprivation processes, diabetes, wound healing, stress response, apoptosis, metastasis, tumorigenesis, cell migration, cell motility in extracellular matrix and cell growth in extracellular matrix, and the factor is a polypeptide comprising an amino acid sequence according to SEQ ID. NO. 1 or a polypeptide having a sequence according to databank entries gi 9506687 or NP_061931, preferably NP_061931.1.
机译:本发明涉及编码参与生物过程的因子的核酸,其中该过程是PI 3激酶途径调节的过程,优选选自葡萄糖代谢,氨基酸和葡萄糖剥夺过程的过程,糖尿病,伤口愈合,应激反应,细胞凋亡,转移,肿瘤发生,细胞迁移,细胞外基质中的细胞运动以及细胞外基质中的细胞生长,并且该因子是包含根据SEQ ID.1的氨基酸序列的多肽。没有。 1或具有根据数据库条目gi 9506687或NP_061931,优选NP_061931.1的序列的多肽。

著录项

  • 公开/公告号IL167801A

    专利类型

  • 公开/公告日2012-10-31

    原文格式PDF

  • 申请/专利权人 SILENCE THERAPEUTICS AG;

    申请/专利号IL20050167801

  • 发明设计人

    申请日2005-03-31

  • 分类号A61K38;A61P35;C07K14;C07K14/47;C12N15/12;

  • 国家 IL

  • 入库时间 2022-08-21 17:24:48

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号